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hLETTER TO THE EDITOR /Cardiovascular
Unusual endomyocardial ﬁbrosis
with  apical calciﬁcation
Dear  Editor,
Endomyocardial  ﬁbrosis  (EMF)  is  a  rare  condition  in  west-
ern  countries  [1].  EMF  is  characterized  by  thickening  of
one  or  both  ventricular  endocardia  with  dense  and  white
ﬁbrous  tissue  that  often  extends  to  the  inner  third  of
the  myocardium,  causing  cavity  obliteration  and  restric-
tion  of  blood  ventricular  ﬁlling.  EMF  represents  the  second
main  cause  of  restrictive  cardiomyopathies.  EMF  usually
occurs  in  a  context  of  hypereosinophilic  syndrome.  How-
ever,  its  diagnosis  might  be  difﬁcult  in  the  absence  of
hyperoesinophilia  [2].  The  initial  stage  of  the  disease  is
generally  characterized  by  a  hypereosinophila  and  then
regression  in  the  later  ‘‘ﬁbrotic’’  phase  [1].  The  etiology  of
this  disease  is  still  unclear  and  different  causes  have  been
suggested:  infections  (toxoplasmosis,  malaria,  helminthia-
sis),  chronic  inﬂammatory  disease  (rheumatoid  arthritis),
allergies  (hypereosinophilia,  autoimmunity),  malnutrition,
and  toxic  agents  such  as  alcohol  [3].  Echocardiography  is
the  ﬁrst-line  imaging  technique  permitting  morphological,
functional,  and  hemodynamic  analysis  of  the  heart  in  daily
practice  [2].  However,  echocardiography  does  not  allow  tis-
sue  characterization  and  cardiac  biopsy  is  still  needed  to
conﬁrm  EMF  [4].
We  report  herein  EMF  in  a  55-year-old  man  referred  to
our  hospital  for  acute  heart  failure.  Patient  had  history  of
alcohol  abuse  and  was  a  current  smoker.  Clinical  exami-
nation  was  consistent  with  global  heart  failure  associated
with  mild  chest  pain  at  rest.  Electrocardiogram  revealed
isolated,  incomplete  left  bundle  branch  block.  Blood  tests
were  unremarkable  except  for  elevation  of  heart  failure
a
c
c
(iomarkers  (elevated  BNP  level).  Emergency  coronary
ngiogram  showed  no  remarkable  abnormalities.
Transthoracic  echocardiography  showed  moderate  left
entricular  dysfunction  without  diastolic  impairment.  Left
entricular  volume  was  reduced  and  the  ventricular  ﬁlling
attern  was  restrictive,  without  atrial  dilation,  and  most
mportantly  a  large,  calciﬁed  apical  mass  was  noted.
Cardiac  magnetic  resonance  imaging  (CMRI)  was  per-
ormed  for  better  tissue  characterization.  SSFP-cine
evealed  a  global  left  ventricular  hypokinesia  associated
ith  apical  hypertrophy.  First  pass  perfusion  images  during
dministration  of  gadoterate  meglumine  (Dotarem®,  Lab-
ratoires  Guerbet,  Roissy-Charles  de  Gaulle,  France)  were
cquired  as  previously  described  [5]. A  marked  hyposignal
ith  no  enhancement  of  the  apical  zone  with  an  unequiv-
cal  presence  of  a  mass  consistent  with  calciﬁcation  was
bserved  (Fig.  1).  Ten  minutes  after  contrast  administration,
ate  gadolinium-chelate  enhanced  images  revealed  a  three-
ayered  appearance  consisting  of  an  outermost  hypointense
ayer  of  normal  myocardium,  a  middle  high-signal  intensity
nhancing  layer  of  endocardium  ﬁbrosis,  and  an  innermost
ypo-intense  layer  of  thrombus  or  calciﬁcations  (Fig.  2).
Recent  studies  showed  that  CMRI  is  a  robust  technique  for
he  diagnosis  of  EMF  [4].  Indeed,  a  typical  3-layer  appear-
nce  of  the  myocardium  has  been  described:  an  inner  layer
howing  no  perfusion  due  to  presence  of  thrombus,  a  mid-
le  layer  on  late  gadolinium-chelate  enhanced  MR  images
eﬂecting  the  ﬁbrotic  tissue  and  an  outer  layer  of  normal
yocardium.  An  excellent  correlation  was  found  between
istopathologic  examination  and  CMR  ﬁndings.
Finally,  cardiac  CT  in  this  particular  patient  had  an
dditional  diagnostic  value  by  distinguishing  thrombus  from
alciﬁcation  commonly  present  in  EMF,  which  is  hardly  dis-
riminated  on  late  gadolinium  chelate  enhanced  MR  images
Fig.  2).
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Figure 1. Long axis three-chamber view (upper panel) and long axis two chamber view (lower panel) of the left ventricle using SSFP
sequence before (left panel) and after gadolinium-chelate injection (right panel). Diffusion of gadolinium-chelate within the myocardium,
immediately after injection better show the three-layered appearance of the apex.
Letter  to  the  editor  1217
Figure 2. CMR images performed 10 minutes after gadolinium-chelate injection in long axis three and four chamber view (panel A and B)
and a short axis view centered on the apex (panel C). The ‘‘so called’’ late gadolinium-chelate enhanced images better show the typical
view 
[
http://dx.doi.org/10.1016/j.diii.2015.04.009three-layered appearance of EMF. Panel D displays a four-chamber 
the apex.
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